Bioavailability refers to the rate and amount of drug that reaches systemic circulation after administration. It is calculated by comparing the amount of drug absorbed to the amount administered, such as 70% bioavailability if 70 mg of a 100 mg oral dose is absorbed. Factors that influence bioavailability include first-pass hepatic metabolism, drug solubility, chemical instability, and formulation properties like particle size. Bioequivalence means two drug formulations have comparable bioavailability and times to peak concentrations, while therapeutic equivalence means they are pharmaceutically equivalent and have similar clinical and safety profiles.
Bioavailability refers to the rate and amount of drug that reaches systemic circulation after administration. It is calculated by comparing the amount of drug absorbed to the amount administered, such as 70% bioavailability if 70 mg of a 100 mg oral dose is absorbed. Factors that influence bioavailability include first-pass hepatic metabolism, drug solubility, chemical instability, and formulation properties like particle size. Bioequivalence means two drug formulations have comparable bioavailability and times to peak concentrations, while therapeutic equivalence means they are pharmaceutically equivalent and have similar clinical and safety profiles.
Bioavailability refers to the rate and amount of drug that reaches systemic circulation after administration. It is calculated by comparing the amount of drug absorbed to the amount administered, such as 70% bioavailability if 70 mg of a 100 mg oral dose is absorbed. Factors that influence bioavailability include first-pass hepatic metabolism, drug solubility, chemical instability, and formulation properties like particle size. Bioequivalence means two drug formulations have comparable bioavailability and times to peak concentrations, while therapeutic equivalence means they are pharmaceutically equivalent and have similar clinical and safety profiles.
drug reaches the systemic circulation For example If 100 mg of a drug is administered orally and 70 mg is absorbed unchanged Bioavailability 70% Important for calculating drug dosages Determination of bioavailability • Determined by comparing plasma levels of a drug after a particular route of administration • With levels achieved by IV administration • IV rout have 100% bioavailability • Plotting plasma concentrations of the drug versus time • Area under the curve (AUC) can be measured • Total AUC reflects the extent of absorption of the drug Factors that influence bioavailability • First-pass hepatic metabolism: • When a drug is absorbed from the GI tract • Enters the portal circulation before entering the systemic circulation • If the drug is rapidly metabolized in the liver or gut wall • Amount of unchanged drug entering the systemic circulation is decreased • Solubility of the drug: • Very hydrophilic drugs are poorly absorbed • Their inability to cross lipid-rich cell membranes • Extremely lipophilic are also poorly absorbed • They are totally insoluble in aqueous body fluids • For a drug to be readily absorbed, it must be largely lipophilic • Also be solubility in aqueous solutions • That why many drugs are either weak acids or weak bases • Chemical instability: • Drugs like penicillin G, is unstable in the pH of the gastric contents • Destroy at acidic pH • Insulin, are destroyed in the GI tract by degradative enzymes • Bioavailability of such a drug is low • Nature of the drug formulation: • Absorption altered by factors unrelated to the chemistry of the drug • For example • Particle size, salt form • Crystal polymorphism, enteric coatings • Presence of excipients (such as binders & dispersing agents) • That influence the ease of dissolution & therefore, alter the rate of absorption Bioequivalence
• Two drug formulations are
bioequivalent if they show comparable bioavailability and similar times to achieve peak blood concentrations Therapeutic equivalence • Two drug formulations are therapeutically equivalent if they are • Pharmaceutically equivalent (that is, they have the same dosage form, contain the same active ingredient • Use the same route of administration) • With similar clinical and safety profiles